17 July 2018 | News
The Ministry of Public Health at Qatar has recalled seven pharmaceutical products on the suspicion of them having carcinogenic properties.
Image credit- sandypines.com
The Ministry of Public Health at Qatar has recalled seven pharmaceutical products that contain the ingredient Valsartan, manufactured by Chinese company Zhejiang Huahai Pharmaceutical LT, on the suspicion of them having carcinogenic properties.
The list of recalled products include Cinfaval and Co-cinfaval manufactured by Spanish Cinfa Laboratories, as well as Diostar and Diostar plus manufactured by Jordan's Pharma International Co, Anginet and Co-Anginet produced by the Jordanian United Pharmaceuticals Manufacturing Co and Valzaar manufactured by the Indian Torrent Pharmaceuticals.
The ministry has revealed that other products that contain the active substance Valsartan manufactured by other companies are safe and are not included in the withdrawal process.
The department is taking all preventative procedures to stop the circulation of any pharmaceutical product that does not meet the international standards.